These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37262040)

  • 21. No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds.
    Coulibaly YI; Sangare M; Dolo H; Soumaoro L; Coulibaly SY; Dicko I; Diabaté AF; Diarra L; Coulibaly ME; Doumbia SS; Diallo AA; Dembele M; Koudou BG; Bockarie MJ; Kelly-Hope LA; Klion AD; Nutman TB
    Parasitol Res; 2022 Nov; 121(11):3243-3248. PubMed ID: 36066741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
    Boko-Collins PM; Ogouyemi-Hounto A; Adjinacou-Badou EG; Gbaguidi-Saizonou L; Dossa NI; Dare A; Ibikounle M; Zoerhoff KL; Cohn DA; Batcho W
    Parasit Vectors; 2019 May; 12(1):276. PubMed ID: 31146779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
    Martin D; Wiegand R; Goodhew B; Lammie P; Mkocha H; Kasubi M
    Am J Trop Med Hyg; 2018 Oct; 99(4):937-939. PubMed ID: 30062986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.
    Bah YM; Paye J; Bah MS; Conteh A; Redwood-Sawyerr V; Sonnie M; Veinoglou A; Koroma JB; Hodges MH; Zhang Y
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008877. PubMed ID: 33370270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
    Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
    Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
    Minetti C; Tettevi EJ; Mechan F; Prada JM; Idun B; Biritwum NK; Osei-Atweneboana MY; Reimer LJ
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006994. PubMed ID: 30608931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    Clin Infect Dis; 2021 Sep; 73(6):994-1002. PubMed ID: 33728462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress on elimination of lymphatic filariasis in Sierra Leone.
    Koroma JB; Sesay S; Conteh A; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y
    Parasit Vectors; 2018 Jun; 11(1):334. PubMed ID: 29866207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
    Eneanya OA; Gankpala L; Goss CW; Momolu AT; Nyan ES; Gray EB; Fischer K; Curtis K; Bolay FK; Weil GJ; Fischer PU
    Acta Trop; 2022 Jul; 231():106437. PubMed ID: 35405102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
    Vanamail P; Ramaiah KD; Subramanian S; Pani SP; Yuvaraj J; Das PK
    Ann Trop Med Parasitol; 2005 Apr; 99(3):237-42. PubMed ID: 15829133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017.
    Graves PM; Joseph H; Coutts SP; Mayfield HJ; Maiava F; Ah Leong-Lui TA; Tupuimatagi Toelupe P; Toeaso Iosia V; Loau S; Pemita P; Naseri T; Thomsen R; Berg Soto A; Burkot TR; Wood P; Melrose W; Aratchige P; Capuano C; Kim SH; Ozaki M; Yajima A; Lammie PJ; Ottesen E; Hansell L; Baghirov R; Lau CL; Ichimori K
    Adv Parasitol; 2021; 114():27-73. PubMed ID: 34696844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach.
    Goss CW; O'Brian K; Dubray C; Fischer PU; Hardy M; Jambulingam P; King CL; Laman M; Lemoine JF; Robinson LJ; Samuela J; Subramanian S; Supali T; Weil GJ; Schechtman KB
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007541. PubMed ID: 31314753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
    Sankari T; Subramanian S; Hoti SL; Pani SP; Jambulingam P; Das PK
    Parasitol Res; 2021 Jan; 120(1):311-319. PubMed ID: 33146778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.